Detalles de la búsqueda
1.
The Clinical and Molecular Profile of Lung Cancer Patients Harboring the TP53 R337H Germline Variant in a Brazilian Cancer Center: The Possible Mechanism of Carcinogenesis.
Int J Mol Sci
; 24(20)2023 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37894716
2.
A phase 2 study of first-line nivolumab in patients with locally advanced or metastatic cutaneous squamous-cell carcinoma.
Cancer
; 128(24): 4223-4231, 2022 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36274573
3.
Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial.
Support Care Cancer
; 30(3): 2225-2236, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34708311
4.
Exercise prescription for symptoms and quality of life improvements in lung cancer patients: a systematic review.
Support Care Cancer
; 29(1): 445-457, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32388616
5.
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.
Lancet
; 394(10212): 1915-1928, 2019 11 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31679945
6.
Impact of pandemic COVID-19 outbreak on oral mucositis preventive and treatment protocols: new perspectives for extraoral photobiomodulation therapy.
Support Care Cancer
; 28(10): 4545-4548, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32696245
7.
ASTRIS: a global real-world study of osimertinib in >3000 patients with EGFR T790M positive non-small-cell lung cancer.
Future Oncol
; 15(26): 3003-3014, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31339357
8.
First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study.
Lancet
; 389(10072): 917-929, 2017 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28126333
9.
De-escalation treatment of human papillomavirus-positive oropharyngeal squamous cell carcinoma: an evidence-based review for the locally advanced disease.
Curr Opin Oncol
; 30(3): 146-151, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29474271
10.
Locally advanced oral squamous cell carcinoma patients treated with photobiomodulation for prevention of oral mucositis: retrospective outcomes and safety analyses.
Support Care Cancer
; 26(7): 2417-2423, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29423682
11.
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.
Lancet
; 387(10027): 1540-1550, 2016 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-26712084
12.
Correction to: Impact of pandemic COVID-19 outbreak on oral mucositis preventive and treatment protocols: new perspectives for extraoral photobiomodulation therapy.
Support Care Cancer
; 29(7): 4177, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33913008
13.
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.
Lancet Oncol
; 16(5): 583-94, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25892145
14.
Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study.
Lancet Oncol
; 16(3): 328-37, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25701171
15.
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial.
J Clin Oncol
; 42(2): 192-204, 2024 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38039427
16.
Health Services Access Inequalities in Brazil Result in Poorer Outcomes for Stage III NSCLC-RELANCE/LACOG 0118.
JTO Clin Res Rep
; 5(3): 100646, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38434771
17.
Patients' choices, quality of life and treatment selection in head and neck cancer.
Curr Opin Oncol
; 30(3): 143-145, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29474270
18.
Predicting survival in metastatic non-small cell lung cancer patients with poor ECOG-PS: A single-arm prospective study.
Cancer Med
; 12(4): 5099-5109, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36161783
19.
Does Multidisciplinary Team Management Improve Clinical Outcomes in NSCLC? A Systematic Review With Meta-Analysis.
JTO Clin Res Rep
; 4(12): 100580, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38046377
20.
Increased sympathetic nervous system impairs prognosis in lung cancer patients: a scoping review of clinical studies.
Lung Cancer Manag
; 12(4): LMT63, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38239811